Alx Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
About Alx Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kode Sudha and Kode Kiran serve as directors at the Company.
- CIN/LLPIN
U24303KA2019PTC128930
- Company No.
128930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2019
- Date of AGM
02 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bengaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Alx Biotech Private Limited offer?
Alx Biotech Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Spices Extracts, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Bird Food, Poultry & Animal Food, Feed Additives, Pharma Ingredients & Raw Materials, Vitamin Powder API, Flavours & Aromatics, Food Emulsifiers.
Who are the key members and board of directors at Alx Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kode Sudha  | Managing Director | 19-Oct-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kode Kiran | Director | 19-Oct-2019 | Current |
Financial Performance of Alx Biotech.
Alx Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Alx Biotech?
In 2020, Alx Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arunachalamm Renewable Energy Private LimitedActive 10 years 10 monthsKode Sudha and Kode Kiran are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alx Biotech?
Unlock and access historical data on people associated with Alx Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alx Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alx Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
